Robert E Abernathy's Net Worth

$49.1 Million

Estimate Recalculated Jun 7, 2024 03:18PM EST

Who is Robert E Abernathy?

Robert E Abernathy has an estimated net worth of $49.1 Million. This is based on reported shares across multiple companies, which include RADIOSHACK CORP, AVIENT CORP, Halyard Health, Inc., HAEMONETICS CORP, LUBRIZOL Corp, and KIMBERLY CLARK CORP.

SEC CIK

Robert E Abernathy's CIK is 0001222888

Past Insider Trading and Trends

2012 was Robert E Abernathy's most active year for acquiring shares with 20 total transactions. Robert E Abernathy's most active month to acquire stocks was the month of March. 2009 was Robert E Abernathy's most active year for disposing of shares, totalling 20 transactions. Robert E Abernathy's most active month to dispose stocks was the month of March. 2011 saw Robert E Abernathy paying a total of $10,107,555.96 for 260,938.881 shares, this is the most they've acquired in one year. In 2011 Robert E Abernathy cashed out on 395,943 shares for a total of $12,626,074.93, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RADIOSHACK CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 2
Form 4
+100.00%
100K
$2.55
$255,010.60
200K
Aug 2 - Aug 5
Form 4
0
0
Jun 3
Form 4
100K
$2.53
$253,000.00
100K
Jul 27
Form 4
0
0
Jun 22
Form 4
0
0
Mar 30
Form 4
0
0
Feb 16
Form 3
0
0
No matching records found

AVIENT CORP (AVNT) Snapshot price: $36.08

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.54%
808
32.59K
Mar 29
Form 4
+2.69%
834
31.78K
Dec 29
Form 4
+3.28%
984
30.95K
Sep 29
Form 4
+2.97%
863
29.96K
Jun 30
Form 4
+3.03%
857
29.1K
Mar 31
Form 4
+3.82%
1.04K
28.24K
Dec 31
Form 4
+4.37%
1.14K
27.2K
Sep 30
Form 4
+3.49%
880
26.07K
Jun 30
Form 4
+2.93%
717
25.18K
Mar 31
Form 4
+2.63%
627
24.47K
Dec 31
Form 4
+3.22%
744
23.84K
Sep 30
Form 4
+2.98%
669
23.1K
Jun 30
Form 4
+3.14%
682
22.43K
Mar 31
Form 4
+3.84%
804
21.75K
Dec 31
Form 4
+6.09%
1.2K
20.94K
Sep 30
Form 4
+6.76%
1.25K
19.74K
Jun 30
Form 4
+10.16%
1.71K
18.49K
Mar 31
Form 4
+5.53%
879
16.79K
Dec 31
Form 4
+6.72%
1K
15.91K
Sep 30
Form 4
+7.62%
1.05K
14.9K
Jun 30
Form 4
+8.70%
1.11K
13.85K
Mar 31
Form 4
+9.91%
1.15K
12.74K
Dec 31
Form 4
+627.75%
10K
$30.64
$306,422.00
11.59K
Oct 25
Form 4
+87.85%
745
1.59K
Sep 30
Form 4
+351.06%
660
848
Jun 30
Form 4
188
188
Mar 31
Form 3
0
0
No matching records found

Halyard Health, Inc. (AVNS) Snapshot price: $18.97

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 3
Form 4
-22.95%
-18.37K
$39.50
-$725,457.00
61.68K
Apr 30
Form 4
0
0
May 5
Form 4
+14.28%
10K
$31.06
$310,600.00
80.04K
Sep 4
Form 4
0
0
May 5
Form 4
0
0
Mar 5
Form 4
+603.10%
60.08K
70.04K
Nov 7
Form 3
0
0
No matching records found

HAEMONETICS CORP (HAE) Snapshot price: $77.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.47%
2.23K
20.08K
Aug 4
Form 4
+18.05%
2.73K
17.86K
Aug 5
Form 4
+25.54%
3.08K
15.13K
Aug 6
Form 4
+49.70%
4K
$80.93
$323,720.00
12.05K
Aug 11
Form 4
+32.70%
1.98K
8.05K
Jul 21
Form 4
+31.70%
1.46K
6.07K
Jul 24
Form 4
+58.30%
1.7K
4.61K
Jul 26
Form 4
2.91K
$45.30
$131,763.16
2.91K
Oct 17
Form 3
0
0
No matching records found

LUBRIZOL Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+34.84%
1.27K
4.91K
Apr 28
Form 4/A
+142.00%
1.42K
$42.27
$60,016.30
2.42K
Apr 24
Form 3
0
0
No matching records found